Daniel Passeri

Insider Reports History

Entity
Individual
Location
40 Guest Street, Boston, MA
Signature
/s/ Daniel Passeri by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Passeri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 135K $371K $2.76 Aug 14, 2023 Direct
Cue Biopharma, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (right to buy) 400K Mar 6, 2024 Direct

Insider Reports Filed by Daniel Passeri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CUE Cue Biopharma, Inc. Mar 6, 2024 1 $0 4 Mar 8, 2024 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Aug 14, 2023 1 $8.58K 4 Aug 16, 2023 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Jul 21, 2023 1 $0 4 Jul 25, 2023 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Mar 31, 2022 4 -$157K 4 Apr 4, 2022 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Mar 25, 2022 1 $0 4 Mar 29, 2022 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Sep 30, 2021 3 -$462K 4 Oct 8, 2021 CHIEF EXECUTIVE OFFICER, Director
CUE Cue Biopharma, Inc. Sep 24, 2021 1 $50.1K 4 Sep 27, 2021 CHIEF EXECUTIVE OFFICER, Director